Rodney Young

2019 - RAPT Therapeutics

In 2019, Rodney Young earned a total compensation of $2.3M as Chief Financial Officer at RAPT Therapeutics.

Compensation breakdown

Bonus$100,000
Option Awards$2,164,134
Salary$32,083
Total$2,296,217

Young received $2.2M in option awards, accounting for 94% of the total pay in 2019.

Young also received $100K in bonus and $32.1K in salary.

Rankings

In 2019, Rodney Young's compensation ranked 5,247th out of 13,971 executives tracked by ExecPay. In other words, Young earned more than 62.4% of executives.

ClassificationRankingPercentile
All
5,247
out of 13,971
62nd
Division
Manufacturing
1,951
out of 5,701
66th
Major group
Chemicals And Allied Products
689
out of 2,200
69th
Industry group
Drugs
580
out of 1,886
69th
Industry
Pharmaceutical Preparations
432
out of 1,398
69th
Source: SEC filing on April 29, 2020.

Young's colleagues

We found three more compensation records of executives who worked with Rodney Young at RAPT Therapeutics in 2019.

2019

Brian Wong

RAPT Therapeutics

Chief Executive Officer

2019

Dirk Brockstedt

RAPT Therapeutics

Chief Scientific Officer

2019

William Ho

RAPT Therapeutics

Chief Medical Officer

News

In-depth

You may also like